๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dementia with Lewy bodies in Down's syndrome

โœ Scribed by Martine Simard; Robert van Reekum


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
102 KB
Volume
16
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

The association between Down's syndrome (DS) and Alzheimer's disease is well established. This paper presents a review of the literature, suggesting a possible association between DS and the more recently recognised dementia with Lewy bodies (DLB). Patients with DLB frequently present with changes in affect and behaviour, and in particular with psychotic symptoms. The literature suggests a possible role for atypical neuroleptics in the management of psychosis in DLB. Copyright ยฉ 2001 John Wiley & Sons, Ltd.


๐Ÿ“œ SIMILAR VOLUMES


Dementia in people with Down's syndrome
โœ Janette Tyrrell; Mary Cosgrave; Mary McCarron; Janet McPherson; Johnston Calvert ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB

## Abstract ## Objectives To determine the prevalence of dementia in an Irish sample of people with Down's syndrome (DS) and to examine associated clinical characteristics of dementia in this group. ## Method 285 people with DS (Age 35โ€“74 years, mean ageโ€‰ยฑโ€‰SD 46.5โ€‰ยฑโ€‰8.2 years) were included in t

Treatment of dementia with Lewy bodies a
โœ Werner Poewe ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 67 KB

Cognitive decline and dementia affect approximately 30% to 40% of patients with idiopathic Parkinson's disease during the course of their illness. PD-dementia (PDD) and dementia with Lewy bodies (DLB) are second to Alzheimer's disease in causing degenerative dementia in the elderly. The nosological

Olanzapine in dementia with Lewy bodies:
โœ Zuzana Walker; Jan Grace; Ross Overshot; Sandya Satarasinghe; Alan Swan; Corneli ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 110 KB ๐Ÿ‘ 2 views

Objectives. Dementia with Lewy bodies (DLB) is now a well-recognized form of dementia in which psychosis and behavioural disturbance are common. Treatment with conventional neuroleptics is often very poorly tolerated. Olanzapine, a newly introduced atypical neuroleptic which binds to multiple recept